• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自发性腹膜炎患者的小肠细菌过度生长与抗菌能力

Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis.

作者信息

Chang C S, Yang S S, Kao C H, Yeh H Z, Chen G H

机构信息

Dept of Internal Medicine, Taichung Veterans General Hospital, Taiwan, Republic of China.

出版信息

Scand J Gastroenterol. 2001 Jan;36(1):92-6. doi: 10.1080/00365520150218110.

DOI:10.1080/00365520150218110
PMID:11218245
Abstract

BACKGROUND

Spontaneous bacterial peritonitis (SBP) is a serious infection in cirrhotic patients with ascites. Both defects in the host defense mechanisms and the enhancement of the offensive factor (small intestinal bacterial overgrowth (SIBO)) may contribute to the development of SBP. Therefore, the aim of this study was to evaluate the role of SIBO versus various antimicrobial capacities in the pathogenesis of SBP in cirrhotic patients.

METHODS

Forty-five cirrhotic patients were enrolled in this study. Bacterial overgrowth was evaluated by breath hydrogen test (BH2T). The hepatic reticuloendothelial system phagocytic index (HRESPI) was measured by intravenously injected colloid suspensions.

RESULTS

The Child-Pugh scores in the SBP group were higher than in the non-SBP group (10.5 +/- 2.0 versus 8.0 +/- 1.8, P < 0.01). The ascitic protein concentration was significantly lower in the SBP group than in the non-SBP group (897 +/- 425 mg/l versus 1,325 +/- 453 mg/l, P < 0.01). Furthermore, the serum C3 concentration was lower in the SBP group than in the non-SBP group (43.1 +/- 13.6 ng/dl versus 73.2 +/- 26.4 ng/dl, P < 0.01). The serum C4 concentration was also lower in the SBP group than in the non-SBP group (12.4 +/- 4.0 ng/dl versus 16.9 +/- 6.6 ng/dl, P < 0.05). The incidence of SIBO was higher in the SBP group than in the non-SBP group (68.2% versus 17.4%, P < 0.01). HRESPI values were significantly higher in the two groups of cirrhotic patients than in the normal reference. However, there were no statistical differences in HRESPI between the two groups (8.4 +/- 2.8 min in the SBP group versus 7.9 +/- 2.8 min in the non-SBP group).

CONCLUSIONS

The results of this study showed that the hepatic reticuloendothelial function is impaired in cirrhotic patients, but the degree of impairment does not differ between patients with and without previous history of SBP. Lower ascitic total protein, lower serum C3 and C4 concentrations, and presence of SIBO are all risk factors for SBP. Based on the results of our study, defects in the host defense mechanisms and the enhancement of the offensive factor (SIBO) may act in concert for the development of SBP.

摘要

背景

自发性细菌性腹膜炎(SBP)是肝硬化腹水患者的一种严重感染。宿主防御机制缺陷和进攻性因素(小肠细菌过度生长(SIBO))增强均可能导致SBP的发生。因此,本研究旨在评估SIBO与各种抗菌能力在肝硬化患者SBP发病机制中的作用。

方法

本研究纳入了45例肝硬化患者。通过呼气氢试验(BH2T)评估细菌过度生长情况。通过静脉注射胶体悬浮液测量肝网状内皮系统吞噬指数(HRESPI)。

结果

SBP组的Child-Pugh评分高于非SBP组(10.5±2.0比8.0±1.8,P<0.01)。SBP组的腹水蛋白浓度显著低于非SBP组(897±425mg/l比1325±453mg/l,P<0.01)。此外,SBP组的血清C3浓度低于非SBP组(43.1±13.6ng/dl比73.2±26.4ng/dl,P<0.01)。SBP组的血清C4浓度也低于非SBP组(12.4±4.0ng/dl比16.9±6.6ng/dl,P<0.05)。SBP组的SIBO发生率高于非SBP组(68.2%比17.4%,P<0.01)。两组肝硬化患者的HRESPI值均显著高于正常对照组。然而,两组之间的HRESPI无统计学差异(SBP组为8.4±2.8分钟,非SBP组为7.9±2.8分钟)。

结论

本研究结果表明,肝硬化患者肝网状内皮功能受损,但有或无SBP既往史的患者之间损伤程度无差异。腹水总蛋白降低、血清C3和C4浓度降低以及存在SIBO均是SBP危险因素。基于本研究结果,宿主防御机制缺陷和进攻性因素(SIBO)增强可能共同作用导致SBP的发生。

相似文献

1
Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis.自发性腹膜炎患者的小肠细菌过度生长与抗菌能力
Scand J Gastroenterol. 2001 Jan;36(1):92-6. doi: 10.1080/00365520150218110.
2
Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.肝硬化合并自发性细菌性腹膜炎患者的小肠动力障碍与细菌过度生长
Hepatology. 1998 Nov;28(5):1187-90. doi: 10.1002/hep.510280504.
3
Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis.肝硬化合并自发性细菌性腹膜炎及未合并自发性细菌性腹膜炎患者腹水补体3水平的研究
Hepatogastroenterology. 2007 Oct-Nov;54(79):1905-7.
4
Serum and ascitic concentration of C3, C4 and protein in cirrhotic patients with spontaneous bacterial peritonitis.自发性细菌性腹膜炎肝硬化患者血清及腹水C3、C4和蛋白质浓度
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):87-92.
5
Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis.肝硬化腹水患者补体C3水平降低易发生自发性细菌性腹膜炎。
J Hepatol. 1988 Feb;6(1):80-4. doi: 10.1016/s0168-8278(88)80465-3.
6
A positive breath hydrogen test does not predict the occurrence of a spontaneous bacterial peritonitis in cirrhotic patients with ascites.呼气氢试验结果为阳性并不能预测肝硬化腹水患者自发性细菌性腹膜炎的发生。
Digestion. 2009;79(4):252-8. doi: 10.1159/000215617. Epub 2009 May 7.
7
Fibronectin in the ascitic fluid of cirrhotic patients: correlation with biochemical risk factors for the development of spontaneous bacterial peritonitis.肝硬化患者腹水中的纤连蛋白:与自发性细菌性腹膜炎发生的生化危险因素的相关性
Braz J Med Biol Res. 1997 Jul;30(7):843-7. doi: 10.1590/s0100-879x1997000700004.
8
[Significance of lipopolysaccharide binding protein in serum and ascites of patients with hepatic cirrhosis complicated with spontaneous bacterial peritonitis].[脂多糖结合蛋白在肝硬化合并自发性细菌性腹膜炎患者血清及腹水中的意义]
Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):492-6. doi: 10.3760/cma.j.issn.1007-3418.2012.07.003.
9
Ascitic Fluid Calprotectin and Serum Procalcitonin as Accurate Diagnostic Markers for Spontaneous Bacterial Peritonitis.腹水钙卫蛋白和血清降钙素原作为自发性细菌性腹膜炎的准确诊断标志物
Gut Liver. 2016 Jul 15;10(4):624-31. doi: 10.5009/gnl15120.
10
[Spontaneous bacterial peritonitis in the patients with liver cirrhosis].肝硬化患者的自发性细菌性腹膜炎
Klin Mikrobiol Infekc Lek. 2004 Dec;10(6):265-70.

引用本文的文献

1
Small Intestinal Bacterial Overgrowth in Patients With Severe Alcoholic Hepatitis: Frequency and Predictors.重症酒精性肝炎患者的小肠细菌过度生长:发生率及预测因素
Cureus. 2025 Jun 7;17(6):e85516. doi: 10.7759/cureus.85516. eCollection 2025 Jun.
2
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders.肠道微生物群与主要非肿瘤性肝胆胰疾病的抗生素治疗
Antibiotics (Basel). 2023 Jun 17;12(6):1068. doi: 10.3390/antibiotics12061068.
3
Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis.
小肠细菌过度生长与肝硬化预后不良相关。
Microorganisms. 2023 Apr 13;11(4):1017. doi: 10.3390/microorganisms11041017.
4
An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis.肝硬化患者自发性细菌性腹膜炎全球患病率、耐药性及转归的流行病学荟萃分析
Front Med (Lausanne). 2021 Aug 5;8:693652. doi: 10.3389/fmed.2021.693652. eCollection 2021.
5
Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients.血清神经酰胺 1-磷酸水平与腹膜透析患者腹膜炎。
Ren Fail. 2020 Nov;42(1):829-835. doi: 10.1080/0886022X.2020.1805763.
6
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.肝硬化患者的小肠细菌过度生长
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):257-267. doi: 10.1016/j.jceh.2018.08.006. Epub 2018 Aug 27.
7
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.肝硬化患者小肠细菌过度生长:系统评价和荟萃分析。
Hepatol Int. 2018 Nov;12(6):567-576. doi: 10.1007/s12072-018-9898-2. Epub 2018 Oct 4.
8
Intestinal permeability in a patient with liver cirrhosis.肝硬化患者的肠道通透性
Ther Clin Risk Manag. 2016 Nov 18;12:1729-1748. doi: 10.2147/TCRM.S115902. eCollection 2016.
9
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.肝硬化中的肠道屏障功能障碍:病理生理学的当前概念及临床意义
World J Hepatol. 2015 Aug 18;7(17):2058-68. doi: 10.4254/wjh.v7.i17.2058.
10
Gut microbiota: its role in hepatic encephalopathy.肠道微生物群:其在肝性脑病中的作用。
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S29-36. doi: 10.1016/j.jceh.2014.12.003. Epub 2014 Dec 16.